365 related articles for article (PubMed ID: 29266838)
1. Identification of differential protein-coding gene expressions in early phase lung adenocarcinoma.
Zhou LN; Li SC; Li XY; Ge H; Li HM
Thorac Cancer; 2018 Feb; 9(2):234-240. PubMed ID: 29266838
[TBL] [Abstract][Full Text] [Related]
2. A comprehensive analysis of candidate genes and pathways in pancreatic cancer.
Liu J; Li J; Li H; Li A; Liu B; Han L
Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614
[TBL] [Abstract][Full Text] [Related]
3. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus.
Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP
World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912
[TBL] [Abstract][Full Text] [Related]
4. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
5. Integrated Analysis of Hub Genes and Pathways In Esophageal Carcinoma Based on NCBI's Gene Expression Omnibus (GEO) Database: A Bioinformatics Analysis.
Yu-Jing T; Wen-Jing T; Biao T
Med Sci Monit; 2020 Aug; 26():e923934. PubMed ID: 32756534
[TBL] [Abstract][Full Text] [Related]
6. Identification of key genes and associated pathways in KIT/PDGFRA wild‑type gastrointestinal stromal tumors through bioinformatics analysis.
Wang WJ; Li HT; Yu JP; Li YM; Han XP; Chen P; Yu WW; Chen WK; Jiao ZY; Liu HB
Mol Med Rep; 2018 Nov; 18(5):4499-4515. PubMed ID: 30221743
[TBL] [Abstract][Full Text] [Related]
7. DNA methylation-based diagnostic and prognostic biomarkers of nonsmoking lung adenocarcinoma patients.
Zhang X; Gao C; Liu L; Zhou C; Liu C; Li J; Zhuang J; Sun C
J Cell Biochem; 2019 Aug; 120(8):13520-13530. PubMed ID: 30920015
[TBL] [Abstract][Full Text] [Related]
8. Identification of differentially expressed genes and enriched pathways in lung cancer using bioinformatics analysis.
Long T; Liu Z; Zhou X; Yu S; Tian H; Bao Y
Mol Med Rep; 2019 Mar; 19(3):2029-2040. PubMed ID: 30664219
[TBL] [Abstract][Full Text] [Related]
9. Identification of differentially expressed genes between lung adenocarcinoma and lung squamous cell carcinoma by gene expression profiling.
Lu C; Chen H; Shan Z; Yang L
Mol Med Rep; 2016 Aug; 14(2):1483-90. PubMed ID: 27356570
[TBL] [Abstract][Full Text] [Related]
10. Identification of stage-specific biomarkers in lung adenocarcinoma based on RNA-seq data.
Liang J; Lv J; Liu Z
Tumour Biol; 2015 Aug; 36(8):6391-9. PubMed ID: 25861020
[TBL] [Abstract][Full Text] [Related]
11. Identification of miRNAs and differentially expressed genes in early phase non-small cell lung cancer.
Tian W; Liu J; Pei B; Wang X; Guo Y; Yuan L
Oncol Rep; 2016 Apr; 35(4):2171-6. PubMed ID: 26781349
[TBL] [Abstract][Full Text] [Related]
12. FN1, SPARC, and SERPINE1 are highly expressed and significantly related to a poor prognosis of gastric adenocarcinoma revealed by microarray and bioinformatics.
Li L; Zhu Z; Zhao Y; Zhang Q; Wu X; Miao B; Cao J; Fei S
Sci Rep; 2019 May; 9(1):7827. PubMed ID: 31127138
[TBL] [Abstract][Full Text] [Related]
13. Identification and validation of key genes associated with non-small-cell lung cancer.
Ma Q; Xu Y; Liao H; Cai Y; Xu L; Xiao D; Liu C; Pu W; Zhong X; Guo X
J Cell Physiol; 2019 Dec; 234(12):22742-22752. PubMed ID: 31127628
[TBL] [Abstract][Full Text] [Related]
14. Bioinformatics approach reveals systematic mechanism underlying lung adenocarcinoma.
Wu X; Zhang W; Hu Y; Yi X
Tumori; 2015; 101(3):281-6. PubMed ID: 26045113
[TBL] [Abstract][Full Text] [Related]
15. Target gene screening and evaluation of prognostic values in non-small cell lung cancers by bioinformatics analysis.
Piao J; Sun J; Yang Y; Jin T; Chen L; Lin Z
Gene; 2018 Mar; 647():306-311. PubMed ID: 29305979
[TBL] [Abstract][Full Text] [Related]
16. Microarray gene expression profiling and bioinformatics analysis reveal key differentially expressed genes in clival and sacral chordoma cell lines.
Li G; Cai L; Zhou L
Neurol Res; 2019 Jun; 41(6):554-561. PubMed ID: 30821656
[TBL] [Abstract][Full Text] [Related]
17. Identification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.
Zhang H; Liu J; Fu X; Yang A
Med Sci Monit; 2017 Dec; 23():5924-5932. PubMed ID: 29240723
[TBL] [Abstract][Full Text] [Related]
18. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis.
Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J
J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306
[TBL] [Abstract][Full Text] [Related]
19. Identifying hepatocellular carcinoma-related hub genes by bioinformatics analysis and CYP2C8 is a potential prognostic biomarker.
Li C; Zhou D; Jiang X; Liu M; Tang H; Mei Z
Gene; 2019 May; 698():9-18. PubMed ID: 30825595
[TBL] [Abstract][Full Text] [Related]
20. Identification of Hub Genes and Pathways in Gastric Adenocarcinoma Based on Bioinformatics Analysis.
Qiu J; Sun M; Wang Y; Chen B
Med Sci Monit; 2020 Feb; 26():e920261. PubMed ID: 32058995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
